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The lifelong generation of αβT cells enables us to continuously build immunity against
pathogens and malignancies despite the loss of thymic function with age. Homeostatic
proliferation of post-thymic naïve and memory T cells and their transition into effector and
long-lived memory cells balance the decreasing output of naïveT cells, and recent research
suggests that also αβT-cell development independent from the thymus may occur. How-
ever, the sites and mechanisms of extrathymic T-cell development are not yet understood
in detail. γδT cells represent a small fraction of the overall T-cell pool, and are endowed
with tremendous phenotypic and functional plasticity. γδT cells that express the Vδ1 gene
segment are a minor population in human peripheral blood but predominate in epithelial
(and inflamed) tissues. Here, we characterize a CD4+ peripheral Vδ1+ γδT-cell subpopula-
tion that expresses stem-cell and progenitor markers and is able to develop into functional
αβT cells ex vivo in a simple culture system and in vivo. The route taken by this process
resembles thymic T-cell development. However, it involves the re-organization of the Vδ1+
γδTCR into the αβTCR as a consequence ofTCR-γ chain downregulation and the expression
of surfaceVδ1+Vβ+TCR components, which we believe function as surrogate pre-TCR.This
transdifferentiation process is readily detectable in vivo in inflamed tissue. Our study pro-
vides a conceptual framework for extrathymicT-cell development and opens up a new vista
in immunology that requires adaptive immune responses in infection, autoimmunity, and
cancer to be reconsidered.
Keywords: extrathymic T-cell development, Vδ1+ γδT cells, T-cell development, δβ heterodimer, inflammation,
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INTRODUCTION
Hematopoietic stem-cells (HSCs) are rare, phenotypically and
functionally diverse cells that can give rise to all cell lineages of
the immune system (1). T-cell development commences when
bone-marrow-derived HSCs seed the thymus. They are the most
immature progenitors and thus constitute the CD4−CD8− dou-
ble negative (DN) T-cell fraction. Stroma- and thymocyte-derived
signals then induce their T-cell lineage commitment and the cells’
differentiation into either αβ or γδT cells through well-defined
stages (DN1–DN4). In humans, these stages can be recognized by
the expression of CD34, CD38, and CD1a surface proteins. The
expression of functionally rearranged TCR-γ and TCR-δ chain
genes in DN2/3 thymocytes leads to γδTCR complexes, which
drive cellular proliferation and promote differentiation into γδT
cells (2,3). In order to become anαβT cell,developing DN3 thymo-
cytes need to express functionally rearranged TCR-β chain genes
that associate with pre-Tαmolecules to form pre-TCR complexes.
The pre-TCR signal drives proliferation, induces transcriptional
silencing of the TCR-γ chain (4) and initiates the transition
of the T cells into CD4+ and CD8+ expressing double-positive
(DP) stages. In humans, this transition involves immature single-
positive (ISP) CD4+ intermediates (5). DP T cells initiate the
rearrangement of TCR-α genes, which leads to the deletion and
thus “silencing” of the TCR-δ chain because the genes encoding
the TCR-δ chain are embedded in the TCR-α locus (6–10). TCR-α
and -β chains form αβTCRs, which are selected for their abil-
ity to recognize peptide-presenting self-MHC molecules (positive
selection). In this repeated process, cells that carry non-functional
TCRs undergo TCR-α rearrangement (11) until selected (2). DP
T cells that recognize self-MHC class I or II molecules below an
acceptable threshold of reactivity (negative selection) develop into
single-positive (SP) CD4+ or CD8+ αβT cells, and are exported
from the thymus into the periphery.
It is undisputed that the thymus provides the foremost source
of naïve T cells and orchestrates normal T-cell lymphopoiesis to
some degree throughout life (12, 13). However, thymic involution
begins as early as 1 year after birth, resulting in an exponentially
decreasing output of naïve T cells, which is almost completely
extinguished post adolescence (14). The total size of the T-cell
pool nevertheless remains relatively constant throughout life (14,
15), which suggests that the T-cell pool must be replenished in
some other way. The decreasing number of naïve T cells is in part
balanced by the proliferation of peripheral, post-thymic T cells,
including naïve(16) and memory αβT cells(16–18), γδT cells(19,
20), and NKT cells(21), leading to effector or long-lived memory
T cells (22–24). Moreover, there is a growing body of evidence
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that suggests that T cells may develop at extrathymic sites in mice
(25) and in humans, e.g., in tonsils (26), lymph nodes, spleen, and
the bone marrow (27–30). However, detailed knowledge about the
precursors, site, and routes of extrathymic T-cell development is
still elusive.
Recent research indicates that HSC – generally present in a
dormant state in a specialized niche in the bone marrow – can
be induced to proliferate and differentiate under conditions of
stress (31–33). It has also been shown that they respond to T-cell
consumption by inducing the proliferation of common lymphoid
progenitors (CLPs), which are the immediate progenitors of T cells
(31–33). Vδ1+ γδT cells are key players in the lymphoid stress-
surveillance response. They constitute a minor T-cell population
in the peripheral blood, but a major subset among tissue-residing
and intraepithelial lymphocytes (34–37).
In this study, we show that the rare and so far unappreciated
entity of human CD4+ Vδ1+ γδT cells, isolated from the periph-
eral γδT-cell pool of healthy individuals, expresses markers that
are characteristic of the earliest hematopoietic progenitor cells, i.e.,
multipotent (MPP) and CLPs. Like thymus-seeding, early T (ETP),
and DN1 progenitors, CD4+ Vδ1+ γδT cells express CD34 and
CD38 but not CD1a (CD34+ CD38+ CD1aneg) on their surface;
they also carry full-length transcripts of in-frame δ, γ, and β TCR
gene rearrangements and express recombination-activating gene
(RAG) and terminal deoxynucleotidyl transferase (TdT), which
are typically found in DN2 and DN3 thymocytes. We show that
CD4+ Vδ1+ γδT cells that lack thymus-homing properties but
carry chemokine receptors (CCR) that direct circulating T cells to
sites of inflammation, can develop into functional, mature CD4+
or CD8+ αβT cells in an inflammatory environment. In this study,
we pinpoint the individual steps of this development, a process
that is very similar to thymic T-cell development, but proceeds
via a Vδ1+Vβ+ intermediate instead of a pre-TCR. We also show
that the progenitors’ cellular intermediates are present in vivo in
inflamed tissue and to a considerably lesser extent in peripheral
blood of healthy individuals.
This fundamentally new role of γδT cells as an αβT-cell pre-
cursor contributes to the emerging concept of T-cell plasticity and
recommends the reconsidering of adaptive immune responses in
infection, autoimmunity, and cancer.
RESULTS
CD4+ Vδ1+ γδT-CELL CLONES DISPLAY CHARACTERISTICS OF A T-CELL
PROGENITOR
In this study, we aimed to characterize the scarce T-cell entity of
CD4+ Vδ1+ γδT cells. We generated CD4+ Vδ1+ γδT clones from
the peripheral blood of 12 healthy individuals, from leukapheresis
products (LPH) of GM-CSF-mobilized healthy stem-cell donors
(n= 12), and also from the bone marrow of potential stem-cell
donors (n= 10). Clones of this phenotype were extremely long-
lived – they could be cultivated uninterruptedly ex vivo for up to
more than a year under standard culture conditions. Importantly,
over time, some clones could change their γδTCR into αβTCR.
The morphology of the CD4+ Vδ1+ γδT-cell clones was similar
to that of large granular lymphocytes (LGLs) (Figure S1A in Sup-
plementary Material). In contrast to most other Vδ1+ cells, their
TCR-γ9+ chain (Figure 1A) contained a constant-region segment
1 (Cγ1) (Figure S1B in Supplementary Material) and was thus able
to form disulfide bonds between TCR-δ and -γ chains (38–40).
To elucidate the nature of the clones’ transdifferentiation from
γδ into αβT cells and to clarify whether the change in TCR consti-
tutes a certain form of TCR revision or whether it is the result of
progenitor differentiation, clones were examined for the expres-
sion of stem-cell and progenitor markers. Although already com-
mitted to T-cell lineage (CD3+) CD4+ Vδ1+ γδT-cell clones nev-
ertheless uniformly expressed CD34lo (22/22), which is the com-
mon marker of most immature hematopoietic stem/progenitor
cells. The clones also expressed C-X-C chemokine receptor type
4 (CXCR4), which maintains the quiescence of the HSC pool
in bone-marrow niches (41), TGF-β, a regulator of hematopoi-
etic stem/progenitor cell self-renewal (42–44), and its receptor
CD105, which, to some extent, indicates a self-sustaining circuit
(Figure 1B). CD4+ Vδ1+ γδT-cell clones expressed a functional
IL-7 receptor (CD127+/CD132+) (Figure 1C), CD117lo(c-kit)
and the FLT3 ligand receptor CD135 (Figure 1B). FLT3 and the
CD117-activated signal transduction cascade promote cell sur-
vival and proliferation. The marker set identified on CD4+ Vδ1+
γδT-cell clones characterizes different progenitors, namely lin−
multipotent hematopoietic progenitors (MPP) as well as CLP in
human bone marrow, as well as linlo ETPs, and canonical DN1 in
the thymus (1). Like DN1-stage T-cell progenitors, CD4+ Vδ1+
γδT-cell clones were CD34+ CD38+ CD1a− (Figure 1D).
Clones that were established directly from the bone marrow –
the place where hematopoietic stem and progenitor cells reside –
expressed significantly higher quantities of CD135 (p= 0.0182)
(69.5± 3.6% cells positive/clone, n= 4) than peripheral blood-
derived clones did (48.7± 6.8% cells positive/clone, n= 4) (Figure
S1C in Supplementary Material), which is evidence for the pres-
ence of a more primitive precursor type in the bone marrow.
Although CD4+ Vδ1+ γδT-cell clones did not initially express
CD2 on their surface, they did so rapidly in the course of cultiva-
tion. This is additional evidence of the CD4+ Vδ1+ T-cell clones’
premature phenotype (Figure 1D). Moreover, CD4+ Vδ1+ clones
transcribed RAG and TdT (Figure 2A), had fully rearranged TCR-
β loci (Figure S1D in Supplementary Material), and the TCR Vβ
protein was readily detectable in the cytoplasm (Figure 2B) and
on the cell surface (Figure S2A in Supplementary Material). Thus
established CD4+ Vδ1+ clones were Vδ1+Cβ+ but not TCRαβ+.
CD4+ Vδ1+ clones were negative for pre-Tα (n= 9) (Figure 2A).
In newly established clones, fully rearranged Vα segments were
found in rare cases in periphery-derived clones, though never
in LPH-derived CD4+ Vδ1+ clones (not shown). This suggests
that the precursors found in the bone marrow are more primitive.
GATA-3 was the major transcription factor while T-bet, RORc, and
Foxp3 were only transcribed at very low levels (Figure 2C). CD4+
Vδ1+ γδT-cell clones spontaneously produced low level regulatory,
TH1- and TH2-related, and proinflammatory cytokines (TGF-β,
IL-2, -4, -5, -6, -10, -13, -17A, IFN-γ, and TNF-α) in standard cul-
ture conditions after stimulating the cells with PMA/ionomycin
(Figure 3A). The CD4+ Vδ1+ γδT-cell clones did not express the
CD45RA antigen, which clearly distinguishes them from recent
thymic emigrants (Figure 3B). CD4+ Vδ1+ γδT-cell clones were
CD45RO+, CD45RA−, CD62L−, CD27−, and CCR7−, and can
thus be classified as effector-memory cells (Figure 3B).
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FIGURE 1 | CD4+ Vδ1+ cells express hematopoietic stem/progenitor
cell markers. (A) CD4+ Vδ1+ T-cell clone TCRs contain a Vγ9 chain and the
cells are CD3+. (B) CD4+ Vδ1+ T-cell clones express the stem-cell and
progenitor markers CD34, CD135 (FLT3), CD117 (c-kit), CD105 (TGF-βR),
and CXCR4 on their surface and express large amounts of TGF-β. Gray line:
isotype control. Histogram marker shows cells that stained positive for
antigen of interest. Numbers indicate mean±SEM of CD4+ Vδ1+ T cells
that stained positive for the respective marker (given in %). Each
histogram shows one representative experiment of all clones tested.
Numbers of clones tested are given in each histogram. (C) Vδ1+ CD4+
T-cell clones express IL-7 receptor composed of α subunit CD127 and the
common γ chain CD132 of IL-2R. (D) FACS analysis showed that CD4+
Vδ1+ T-cell clones are CD34+CD38+CD1aneg, may lack CD2 expression, but
become CD2+ during cultivation.
Thus, CD4+ Vδ1+ γδT-cell clones expressed marker molecules
that are characteristic for a thymus-seeding progenitor (TSP), as
well as DN1–DN4 stage thymocytes and an ISP thymocyte, which
in humans is CD4+.
CD4+ Vδ1+ γδT-CELL CLONES EXPRESS CHEMOKINE RECEPTORS THAT
DIRECT CIRCULATING T CELLS TO SITES OF INFLAMMATION
The function of T cells is strongly connected with their microen-
vironment. CD4+ Vδ1+ γδT cells did not express the chemokine
receptors CCR9 (8/9) and CCR7 (9/9), which makes homing to
the thymus less likely (Figure 4) (45). However, they expressed
five chemokine receptors: CCR4 (46, 47), CXCR1/CXCR2 (48),
CCR6 (49), and CXCR4 (50), which direct the movement of
circulating T cells to sites of tissue injury, infection, inflamma-
tion, and under physiological conditions to the skin (46, 47)
(Figure 4).
CD4+ Vδ1+ γδT-CELL CLONES CAN CHANGE THEIR TCR INTO αβTCR
AND MATURE INTO FUNCTIONAL αβT CELLS
CD4+Vδ1+ γδT-cell clones turned out to be extremely long-lived.
When grown under standard culture conditions, the CD4+ Vδ1+
γδT-cell clones successively downregulated the expression of CD34
on the cell surface (not shown) and some expressed αβ instead
of γδTCR (Figure 5A, top). TCR change occurred rarely under
standard culture conditions – only 1 out of 50 clones changed
their Vδ1+ TCR into αβTCR. TCR change occurred either within
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FIGURE 2 | CD4+ Vδ1+ T-cell clones express RAG andTdT, carryTCR-β
chain in their cytoplasm and transcribe GATA-3. (A) CD4+ Vδ1+ T-cell
clones express RAG mRNA (mean: 23.36±10.27 SEM), TdT mRNA (mean:
1.91±0.72 SEM) but lack pre-Tα mRNA. Shown are mean±SEM;
(B) Vβ-chain protein (red) in the cytoplasm of CD4+ Vδ1+ clones grown under
standard culture conditions, which mimic mild inflammation [blue: DAPI;
Axiophot microscope (Zeiss)]. (C) Transcription factors expressed by CD4+
Vδ1+ T-cell clones, determined by real-time RT-PCR. GATA-3 (mean:
0.22±0.03 SEM), T-bet (mean: 0.0009±0.0002 SEM), Foxp3 (mean:
0.01±0.006 SEM), and RORC (mean: 0.0001±0.00008 SEM).
days or up to 5 months after the establishment of the cell culture
[Vδ1+ clone K1: +3 months and +5 months (different culture
plate), Vδ1+ clone P7: +3 months] (Figure 5A, top). The cells
remained either SP CD4+ or changed their co-receptor from
SP CD4+ to DP CD4+/CD8dim. This led to pools of cells that
were either SP CD4+ and/or SP CD8+ (Figure 5A, bottom). The
CD4+Vδ1+ T-cell clone-derived TCRαβ+ T-cell line K1.1 (K1.1-
αβ+) almost exclusively expressed surface TRBV11-2+ and -4.1+,
and T-cell line K1.2 (K1.2-αβ+) almost exclusively TRBV27+ and
-19+ (Figures S2B,C in Supplementary Material). The clone P7-
derived TCRαβ+ T-cell line did not express TCR Vβ families that
are detectable with available TCR antibodies (data not shown).
All CD4+ Vδ1+ T-cell clone-derived αβT cells were T10B9.1A-
31+ (framework epitope of αβTCR heterodimer),WT31+ (CD3ε),
CD3+, Vδ1neg, γδTCRneg, CD25lo/neg, CD28neg, and were
also terminally differentiated effector-memory RA-re-expressing
T cells (TEMRA) (Figure 5B). The CD4+ Vδ1+ T-cell clone-
derived αβT-cell lines lacked CD103, and therefore did not have a
tissue-resident memory (TRM) phenotype (not shown). Further-
more, they did not transcribe TCR-δ segments, which is due to the
deletion of the TCR-δ locus as a result of the recombination of the
genes that encode the TCR-α chain. Nevertheless, theαβT-cell lines
still transcribed rearranged γ chain segments (Figure 5C). Under
standard culture conditions, the αβT cells derived from clone K1-
Vδ1+ and P7-Vδ1+ produced IL-4 but not IFN-γ. In addition,
they responded to (PMA)/ionomycin stimulation with a (subtle)
increase in IL-4 release and with the substantial de novo produc-
tion of IFN-γ, demonstrating their functionality (Figure 5D).
The αβT cells responded poorly to mitogenic stimuli (data not
shown). The clone C3-23-derived αβT-cell line produced IFN-γ
(41% of the cells) and IL-10 (55% of the cells) when stimulated
with PMA/ionomycin. These are the same cytokines as those pro-
duced in lower quantities under standard culture conditions (not
shown). αβT-cell lines derived from other clones produced mainly
IFN-γ and IL-10.
DEVELOPMENTAL STEPS OF CD4+ Vδ1+ CLONE CELLS IN THE PROCESS
OF TRANSDIFFERENTIATION
In order to study TCR re-organization during transdifferentia-
tion, the expression of the constant region of the TCR chains,
Cδ, Cγ, Cβ (BMA031) and Cα (as a TCR-αβ-associated frame-
work epitope), in CD4+ Vδ1+ clones undergoing TCR change
was monitored. CD4+ Vδ1+ T cells consistently downregulated
the expression of the TCR-γ and TCR-δ chains, thus becoming
Vδ1dim/Cγdim, and then Vδ1lo/neg. cells that lacked Cγ (Figure 6A).
Vδ1lo/neg.Cγneg. cells expressed Cβ on their cell surface. These
Vδ1lo/neg.Cβ -expressing cells were CD4+CD8+ DP and eventu-
ally developed into Vδ1neg.Cβ+ SP CD4+ or SP CD8+ T cells
(Figure 6A). In order to identify the number of αβT cells in
the cultures, we stained for Cβ and TCRαβ in Vδ1+ cell cultures
and found that 84.6%± 8.0 SD of all Vδ1lo/neg. cells expressed
Cβ, while 26.6%± 6.64 SD) of all Cβ+ Vδ1lo/neg. cells stained
positive for TCRαβ (Figure 6B). Cβ+ cells were CD4+CD8+
DP (29.75%± 15 SD), or CD8+ (8.37%± 4.62 SD), or CD4+
(58.38%± 11.21 SD), and in rare cases DN (3.5%± 5.4 SD) (an
example of which is shown for one clone in Figure 6A). TCRαβlo
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FIGURE 3 | CD4+ Vδ1+ T-cell clones have aTH0-cytokine profile
and are effector-memory cells. (A) CD4+ Vδ1+ clones produce
regulatory IL-10 and TGF-β, TH2 cytokines IL-4, -5, and -13, and to a
lesser extent proinflammatory IL-17A and IL-6, and the TH1-cytokines
IL-2, IFN-γ, and TNF-α after stimulation with PMA/ionomycin.
(B) CD4+ Vδ1+ clones were not naïve but belonged to the effector
memory; they were CD45RA−, CD27−, CCR7−, and predominantly
CD62L− and CD28±.
cells then upregulatedαβTCR and could not be distinguished from
peripheral αβT cells (not shown).
INFLAMMATION TRIGGERS DIFFERENTIATION OF Vδ1+ γδT CELLS INTO
αβT CELLS
As TCR change occurred in only one out of 50 established
CD4+ Vδ1+ γδT-cell clones, we purified Vδ1+ γδT cells,
including the DN, CD8+, and CD4+ subsets from peripheral
blood mononuclear cells (PBMNCs) of healthy human donors.
These cells (panVδ1+) were subsequently used to study whether
inflammatory stimuli trigger transdifferentiation. For that two
different inflammatory settings were compared: standard cul-
ture conditions were designated as mild inflammation, whereas
stronger inflammatory stimuli were termed overt inflammation.
PanVδ1+ T cells cultivated in the mild inflammatory environ-
ment (standard culture, see Materials and Methods) gave rise to
a subset of T cells that transdifferentiated into TCRαβ+ T cells
(n= 12) (Figure 7A) within 3–4 weeks. Vδ1+ cells sequentially
changed their TCR, reorganized their Vδ1+ γδTCRint/lo pheno-
type to phenotype Vδ1int/lo/TCR-αβlo, and from the latter to
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FIGURE 4 | CD4+ Vδ1+ T-cell clones express chemokine receptors
associated with inflammation. Vδ1+ CD4+ clones show strong expression
of CCR4, CXCR1, and -2, and express CCR6lo, CCR7lo, and CXCR4lo.
Histogram marker shows cells that are positive for the antigen of interest.
Numbers indicate mean±SEM of CD4+ Vδ1+ T cells that stain positive for the
respective marker (given in %). Each histogram shows one representative
experiment of all clones tested. Numbers of clones tested are given in each
histogram. Gray line: isotype control.
phenotype Vδ1−γδ− TCR-αβ+ (Figure 7A). The percentage of
Vδ1int/lo/TCR-αβlo DP cells correlated exactly with the percent-
age of CD4+ cells in the initial panVδ1+ T-cell pools. However,
the number of Vδ1int/lo/TCR-αβlo DP cells did not correlate with
the low number of αβT cell contaminants found in the initial
culture pool (Figure 7B). The number of CD4+ Vδ1+ T cells
within the panVδ1+ T-cell pool varied greatly between individ-
uals (mean: 0.926% of all Vδ1+ T cells; range: 0.1–3.0%), as
did the number of αβT cells generated from panVδ1+ cell pools
(mean 1.82% of input Vδ1+ T cells; range 0.2–6.4%) (Figure 7B).
Concomitantly with TCR change, RAG-1 and TdT mRNA was
detected in panVδ1+ T-cell pools. TdT is positively regulated by
Tβ4 of which large amounts are expressed by epithelial (Vδ1+)
γδT cells (51) (Figure 7C). Additionally, mRNA isolated from
the panVδ1+ cultures showed that functionally rearranged TRBV
and TRAV segments emerged at the same time as Vδ1int/lo/TCR-
αβlo intermediates (n= 5) did (Figures 8A,B). The modulation of
inflammatory culture conditions resulted in similar, overlapping
TRAV expression patterns (Figure 8C). In contrast, TCR-α chain
transcripts were not present in the aliquots of the initial panVδ1+
T-cell pools. They were not present in panVδ1+ and pan γδT-cell
pools of peripheral blood of healthy donors either (not shown).
The transcription rate of pre-Tα was the same as in the controls
with no template.
In the overt inflammatory approach panVδ1+ T cells received
a combination of cytokines that are pivotal in acute and chronic
inflammation, and monocytes, which had been preactivated with
the same cocktail for three days (see Materials and Methods: overt
inflammation).
Fundamental phenotypic changes were observed at the pro-
tein and transcriptional level. A significant upregulation of CD4
(4.3-fold; p= 0.0487) created (more) Vδ1+ SP CD4+ cells and
the novel phenotype of Vδ1+ CD4+ CD8+ DP T cells in five
out of seven cultures (Figures 9A,B). Simultaneously, the CD8
co-receptor was downmodulated (Figure 9B) and the CD8αα
homodimer was replaced by the CD8αβ heterodimer in a signif-
icant proportion of CD8+ Vδ1+ T cells (Figure 9C) (p= 0.0452,
n= 6). Interestingly, panVδ1+ T cells became weakly positive for
Vβ chains on their surface (Vβ+); most of them expressed TRBV30
(n= 12) as shown by FACS analysis (Figure 9D). In addition, other
Vδ1+ T cells in the panVδ1 T cell pool carried a varying num-
ber of individual TRBV chains on their surface (not shown). It is
worth noting that strong inflammation (as indicated in the Section
“Materials and Methods”) was not associated with the generation
of DP Vδ1+ /TCR-αβ+ or αβT cells. Strong inflammation did not
affect the transcription of RAG (Figure 7C), Vβ-segment usage
(Figure 8A) and complexity score (native: 20.00± 7.21 SEM, mild
infl.: 7.67± 2.96 SEM; overt infl.: 28.43± 7.38 SEM). However,
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FIGURE 5 | CD4+ Vδ1+ T-cell clones change theirTCR intoTCR-αβ and can change their co-receptor.
(Continued)
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FIGURE 5 | Continued
Phenotypic, molecular, and functional characterization of αβT cell lines
exemplarily shown for lines derived from two different clones. (A) Process of
transdifferentiation in a CD4+ Vδ1+ clone. Change of TCR expression (top), and
change of co-receptor expression (bottom). (B) Resulting αβT-cell populations
were heterogeneous. Exemplarily shown are two T-cell lines derived from two
different clones. Their T-cell lines were terminally differentiated
CD45RA-re-expressing T effector-memory cells (TEMRA). Clone
K1-Vδ1+-derived αβT cells were CD8αβ+ and did not express CD28 and CD25.
Clone P7-Vδ1+derived αβT cells were CD4+, lacked CD28 but expressed
CD25int. (C) Molecular analysis of TCR chain δ-, γ-, β-, and α-transcripts in two
CD4+ Vδ1+ clones (K1-Vδ1+ and P7-Vδ1+) and two of the derived αβT-cell lines
(K1.1-αβ+ and P7-αβ+). The generated αβT-cell lines transcribe γ chain(s), but no
δ chain. (D) Clone K1- and P7-Vδ1+-derived αβT cells constitutively secrete IL-4,
but not IFN-γ; upon exposure to PMA/ionomycin they increase IL-4 secretion
and secrete IFN-γ de novo. Gray line: isotype control.
FIGURE 6 | Characterization of the subsets of a CD4+ Vδ1+ clone cells
that changesTCR-γδ intoTCR-αβ. (A) Vδ1+ and Vδ1lo/neg. subpopulation of
CD4+ Vδ1+ T-cell clones examined for the expression of Cγ, Cδ, Cβ, and Cα
(as a TCR-αβ framework epitope) as well as co-receptors. A clone
representative of seven analyzed clones is shown. (B) TCR-αβ+ cells in Vδ1hi
and Vδ1lo/neg. Cβ+-expressing Vδ1+ CD4+ T-cell clone fractions. A clone
representative of seven analyzed clones is shown.
emergence of full-length transcripts of in-frame TRAV-26-2 and
TRAV24 rearrangements in cultures of all donors demonstrated
that the TCR-α locus had been accessible and was recombined
(n= 7) (Figure 8B). TdT was also induced, evidenced through
long stretches of N nucleotides in the TRAV24 sequences (Table 1).
Vα rearrangements, both in panVδ1+ and CD4+ Vδ1+ clone
cultures, exactly followed the hierarchical order of the thymic
rearrangement process that reconciles the sequential opening of
the 3′ end of the V region and the 5′ end of the J region (52).
IDENTIFICATION OF THE Vδ1+CD34DIM PRECURSOR IN VIVO AND ITS
TRANSDIFFERENTIATION INTERMEDIATES IN PHYSIOLOGICAL AND
INFLAMED TISSUE
In order to study the significance of the Vδ1+CD34dim precur-
sor and its transdifferentiation in vivo, its frequency in the bone
marrow was determined. Of all lymphocytes in the bone mar-
row, 0.039% were Vδ1+CD34dim precursors (n= 8, not shown),
which correlated with the number of Vδ1+CD34dim T cells per
Vδ1+ subset in the peripheral blood of diseased individuals, but
was significantly different from their numbers in healthy PBM-
NCs (Figure 10A). However, the overall number of Vδ1+ T cells
was significantly higher in the peripheral blood of diseased sub-
jects [4.6-fold; range: healthy 0.3–2.0 (n= 6), diseased 0.6–8.6
(n= 7)] (Figure 10B), which influences the absolute number
of CD34dim cells in the periphery (Figure 10A). Our diseased
cohort included individuals that suffered from viral infections
(n= 4), lupus erythematosus (n= 1), vitiligo (n= 1), and a viral
infection associated with chronic fatigue syndrome (n= 1). The
Vδ1+CD34dim precursors in the peripheral blood were mostly DN
(52.08%) and CD8 (42.66%) (not shown), which is consistent with
the finding that CD4+ is upregulated by inflammatory stimuli
(Figure 9A).
TCR-γ CHAIN EXPRESSION IN Vδ1+ T CELLS IN VIVO
As TCR change occurred in TCR-γlow/neg.-expressing cells
(Cγlo/neg.), we determined TCR-γ expression in vivo (freshly
drawn peripheral blood) and in native healthy bone marrow.
Unexpectedly, TCR-γ chain (Cγ) expression was significantly
higher in Vδ1+ than in Vδ2+ cells in the blood of healthy
donors and in bone marrow. In contrast, there was a signifi-
cantly higher expression of Cγ in the Vδ2+ than in the Vδ1+
cells in the blood of diseased volunteers and in bone mar-
row. When comparing absolute Cγ expression, the Vδ2+ sub-
set showed a significant upregulation of TCR-γ chain expres-
sion during inflammation, whereas the Vδ1+ subset expressed
the γ-chain constitutively in bone marrow and PBMNCs irre-
spective of inflammatory stimuli. Blood samples were taken
from individuals suffering from uncharacterized viral infection
(n= 3), pneumonia (n= 1), cystitis (n= 2), nephritis (n= 1); (Cγ
MFI mean: Vδ1bone marrow 2360± 188 SEM versus Vδ2bone marrow
1298± 99 SEM; Vδ1healthy 2533± 129 SEM versus Vδ2healthy
1711± 218SEM; Vδ1diseased 2606± 213SEM versus Vδ2 diseased
3986± 256 SEM) (Figure 10C).
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FIGURE 7 | Vδ1+ T cells differentiate into αβT cells. RAG and TdT expression
in panVδ1+ cultures, native and over time in different inflammatory culture
conditions; correlation of TCR DP cells with CD4+Vδ1+ and residual αβT-cell
numbers in initial panVδ1+ T-cell pools. (A) panVδ1+ T cells cultivated in the
presence of IL-7, PHA, IL-2, and irradiated allogeneic feeder cells gave rise to a
cell fraction that co-expressed Vδ1 and TCR-αβ after 3 weeks, before
differentiating into TCR-αβ+ T cells. Series of dot plots are representative of 12
independent experiments. (B) Number of Vδ1+/TCR-αβ+ cells varied between
individuals (mean: 0.926%/Vδ1+; range 0.1–3%) (right) as did the number of
produced αβT cells (mean: 1.82%/Vδ1+; range 0.2–6.0%) (left); Vδ1+/TCR-αβ+
double-positive cells in week 3 of culture corresponded with the number of
CD4+ Vδ1+ T cells in initial Vδ1+ T-cell pool (left). There was no correlation
between residual TCR-αβ+ T cells after Vδ1+ cell separation and set-up of initial
Vδ1+ T-cell culture and the number of Vδ1+/TCR-αβ+ double-positive T cells
after 3 weeks of culture (right). Each dot represents one independent
experiment. (C) After initial depression, RAG-1 and TdT quantities subtly
increased in Vδ1+ cell cultures and were detectable simultaneously with the
appearance of Vδ1+/TCR-αβ+ coexpressing cells. m, Mild inflammation (IL-7,
PHA, IL-2, and irradiated allogeneic feeder cells); o, overt inflammation
(exposure to strong inflammatory stimuli in week 3, conditions described in
the Section “Materials and Methods”); week 0, freshly isolated, native Vδ1+
cells were analyzed.
TCR-β CHAIN EXPRESSION IN Vδ1+ T CELLS IN VIVO
TCR-β chain expression was determined for the Vδ1+ subset and
the αβT-cell compartment in the peripheral blood of healthy
and diseased individuals (Figure 11A). The percentage of Vβ+-
expressing Vδ1+ cells differed highly significantly between healthy
(n= 6; 20.0%± 5.98 SEM) and diseased (n= 5; 77.8%± 13.34
SEM) blood (Figure 11B).
Vδ1+Cβ+ TCR INTERMEDIATES IN PERIPHERAL BLOOD AND AT SITES
OF INFLAMMATION
In order to assess whether the transdifferentiation of CD4+ Vδ1+
γδT cells is of physiological importance, we investigated body
fluids of inflamed tissues for the presence of cellular interme-
diates of the transdifferentiational route. Vδ1+Cβ+ intermedi-
ates were present in significantly larger numbers in body fluids
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FIGURE 8 | Repertoire of fully rearranged and transcribedTRBV andTRAV
segments in panVδ1+ T cell pools that were cultivated in different
inflammatory environments. (A) TRBV-segment usage and
(B) TRAV-segment usage after 3 weeks of culture (C) Comparison of
Vα-segment usage of panVδ1+ T cells from one donor (#2) in different
modified inflammatory environments. +, Treatment combined with
anti-CD40; IL-15 (10 ng/mL) was added to all cultures. Black squares indicate
expression of transcripts of rearranged TCR chains.
Frontiers in Immunology | T Cell Biology December 2014 | Volume 5 | Article 645 | 10
Ziegler et al. Vδ1+T cells can develop into αβT cells
FIGURE 9 | Phenotypic changes of panVδ1+ T cells in inflammatory conditions.
(Continued)
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FIGURE 9 | Continued
(A) Inflammation-induced phenotype of DP CD4+ CD8+ Vδ1+ γδT cells.
(B) Ex vivo overt inflammatory conditions significantly increased the number
of CD4+ T cells in panVδ1+ cell cultures to an extent that was much higher
than that seen in peripheral blood of healthy individuals (p=0.0493) or in mild
inflammation in vitro (p= 0.0487). In comparison to peripheral blood of
healthy individuals, overt inflammation led to a significant reduction of the
number of CD8+ Vδ1+ cells (p=0.0097). (C) Overt inflammation induced the
expression of the CD8αβ heterodimer in a significant proportion of CD8+ Vδ1+
cells (p=0.0452) in 3/3 donors tested. (D) panVδ1+ cells show TRBV30 chains
on the cell surface after 7 days of (both: mild and overt) inflammation (5/5
tested, shown are 3/5); TRBV30 was also observed on clones that were
chronically exposed to mild inflammation (7/7 tested, 3/7 are shown). Gray
line: isotype control. Histogram marker shows range of cells that stained
positive for the antigen under investigation. Numbers indicate mean±SEM of
Vδ1+ (CD4+) T cells that stained positive for the respective marker (given in
%). The histograms show three representative experiments for panVδ1+ T
cells and CD4+ Vδ1+ clones stained with TRBV30. TRBV30 expression was
determined in panVδ1+ cultures with 4 different donors in 3 independent
experiments each, and in 7 CD4+ Vδ1+ clones.
Table 1 | CDR3 region peptide composition of rearrangedTRAV segments in panVδ1+ T cells induced by mild and overt inflammation and CDR3
regions of rearrangedTRBV andTRAV segments of αβT cells derived from CD4+ Vδ1+ clone K1-Vδ1+ (K1.1-αβ+) under mild inflammatory
conditions.
Donor No. of exp. TRAV TRAJ 3′ of V-segment CDR3 J segment Public motif type Reference
MILD INFLAMMATION
1 1 26-2 41 CI LRGL NSGYALNFCKRT. . . 2 N/A
1 26-2 41 CI LRGS NSGYALNFCKRT. . . 2 N/A
2 1 26-2 41 CI LRDW NSGYALNFGKGT. . . 3 N/A
3 1 26-2 41 CI LRDW NSGYALNFGKGT. . . 3 N/A
4 1 26-2 41 CI LRDL NSGYALLFCKRT. . . 3 N/A
5 1 26-2 41 CI LRDL NSGYALLFCKRT. . . 3 N/A
OVERT INFLAMMATION
1 1 26-2 41 CI LRGL NSGYALNFGKGT. . . 3 N/A
2 1 26-2 41 CI LRDL NSGYALNFGKGT. . . 3 N/A
3 1 26-2 41 CI LRDL NSGYALNFGKGT. . . 3 N/A
4 2 26-2 41 CI LRDL NSGYALNFGKGT. . . 3 N/A
5 1 26-2 41 CI LRDL NSGYALNFGKGT. . . 3 N/A
6 3 26-2 41 CI LRGL NSGYALNFGKGT. . . 3 N/A
7 1 26-2 41 CI LRDL NSGYALNFGKGT. . . 3 N/A
4 3 24 3 LA RRNDG SASKIIFGSGT. . . 3 N/A
5 2 24 3 LA RRNDG SASKIIFGSGT. . . 3 N/A
6 2 24 3 LA RRNDG SASKIIFGSGT. . . 3 N/A
α CHAINS OF αβT CELLS DERIVED FROM CLONE K1 UNDER MILD INFLAMMATORY CONDITIONS
K1.1-αβ+ 3 5 CA VRD DTGRRALTFGSGT – N/A
14DV4 17 CA MREGRF KAAGNKLTFGGGT. . . 2 (53)
25 10 CA G TGGGNKLTFGTGT. . . – N/A
26-2 52 CQ LSTARTPTP SQDAVVHSSISQGST 1 (54, 55)
β CHAINS OF αβT CELLS DERIVED FROM CLONE K1 UNDER MILD INFLAMMATORY CONDITIONS
K1.1-αβ+ 11-2 1-1 CAS RRG TEAFFGQGT. . . 2 (56), (57)
19 2-7 CASS SNGQGV YEQYFGPGT. . . 1 (58)
27 2-3 CASS LGDRVA DTQYFGPGT. . . 2 (59)
CDR3 regions of rearranged TRAV segments in panVδ1+ cultures and of rearranged TRBV and TRAV segments in K1-derived αβT cells. (A) top: mild inflammation
induced exclusively TRAV-26-2JC transcripts in panVδ1+ T cells, transcripts of donors J, K, and P were sequenced; overt inflammation also induced TRAV24; TRAV-
derived transcript sequence analysis is shown for all donors and all experiments. (B) CDR3 sequences ofTRBV andTRAV segments, detected in spectratype analysis
as single peaks, were determined from K1-derived αβT cells (K1-17): 3/18 single peaks of TRBV-segments, 4/4 single peaks of TRAV segments. Sequences were
derived from cDNA transcripts after PCR-based spectratype analysis.
of inflamed tissue (synovia of arthritic joints, tumor-associated
ascites, pleural effusion; mean expression 23%± 5.38 SEM; range
0.8–63.2%) than in the peripheral blood of healthy individuals
(mean expression healthy 3.0%; ±0.86 SEM; range 0.6–10.0%)
(Figure 11C).
Given that the transdifferentiation intermediates express the
δ1- and a β-chain for a δβ+ heterodimer, which must occur
in the absence of the TCR-γ chain (60), and given that the α-
chain is not yet rearranged and expressed, the expected result-
ing phenotype after FACS staining with the murine antibody
that targets the γδTCR constant region (clone 11F2) and the
αβTCR framework epitope (T10B9.1A-31) is CD3+, “TCRneg-
ative,” CD4+ or CD8+. This phenotype was detected in all donors
tested (Figure 11D).
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FIGURE 10 | Vδ1+ lymphocytes and Vδ1+ CD34dim T cell population in
blood and marrow. (A) Percentage of Vδ1+ CD34dim T cells/Vδ1+
lymphocytes in peripheral blood of healthy (n=6) and diseased donors
(n=7) and healthy bone marrow (n= 5). The percentage of Vδ1+ CD34dim T
cells/Vδ1+ lymphocytes was significantly higher in native bone marrow
compared to peripheral blood from healthy donors (p=0.0017). (B) The
quantity of Vδ1+ lymphocytes was (highly) significantly increased in the
peripheral blood of diseased (n=13; mean: 5.13± 1.57 SEM; p=0.0096)
and inflamed tissue (n=12; mean: 5.88± 1.52 SEM; p=0.0388) compared
to the quantity observed in the blood of healthy individuals (n=17; mean:
0.89± 0.22 SEM). Vδ1+ lymphocytes were significantly more frequent in
peripheral blood (p=0.0367) and body fluids (p=0.0107) of diseased
individuals than in bone marrow (n=9 mean: 0.85±0.26 SEM).
(C) Absolute expression level of TCR-γ chain on Vδ1+ and Vδ2+ cells in
healthy (n=12) and diseased (n=7) peripheral blood and bone marrow
(n=5). Blood samples included blood from patients with uncharacterized
viral infection (n=3), pneumonia (n=1), cystitis (n= 2), nephritis (n=1) (Cγ
MFI mean: Vδ1bone marrow 2360±188 SEM versus Vδ2bone marrow 1298± 99 SEM;
Vδ1healthy 2533±129 SEM versus Vδ2healthy 1711±218SEM; Vδ1diseased
2606±213SEM versus Vδ2 diseased 3986± 256 SEM).
Thus, our data provide evidence for the existence of a pathway
for extrathymic αβT-cell development from the CD4+Vδ1+ T-cell
precursor as shown in Figure 12.
DISCUSSION
In this study, we identified the human Vδ1+ γδT-cell subset as a
reservoir of a CD4+ cell entity that shows the cumulative expres-
sion of markers and molecules that are pivotal for T-cell prog-
enitor phenotype and function namely CD34dim, FLT3+, c-kitlo,
CD105+, and CXCR4+. Low level and simultaneous expression
of cytokines characterizing multiple Th lineages conforms with
the view that stem-cells possess a wide-open chromatin struc-
ture to maintain their multipotentiality, which is progressively lost
during differentiation (61, 62). The combined expression of five
different chemokine receptors that direct the movement of cir-
culating T cells to sites of inflammation indicates a function of
this progenitor in inflamed tissue. We provide phenotypic, tran-
scriptional and functional evidence that initial CD34dim CD4+
Vδ1+ γδT-cell clones can develop into functional αβT cells in
ex vivo cultures. By monitoring surface expression of the con-
stant region of the 4 different TCR chain loci γ, δ, β and α on
CD34dim CD4+ Vδ1+ γδT cell clones, we identified the CD4+
Vδ1+ γδT cells’ transdifferentiation into αβT cells as a sequential
invariant process that is triggered by (mild) inflammatory stim-
uli (schematically shown in Figure 12). The re-organization of
Vδ1+ TCR-γδ into TCR-αβ was associated with morphological
and physiological changes of the CD4+ Vδ1+ γδT cells reproduc-
ing thymic T-cell development: cultured peripheral CD4+ Vδ1+
γδT cells increased in size, acquired an LGL-like morphology,
downregulated TCR-γ and – to a lesser extent – TCR-δ; they
proliferated vigorously, expressed functionally rearranged TCR-
β chains on their surface, thus forming the Vδ1+Cβ+ cellular
intermediates that traversed into the CD4+CD8+ DP stage. An
increase in RAG and TdT activity preceded the induction of the
rearrangement of the TCRα loci in exact thymic order before the
Vδ1+Cβ+ intermediates shut down Vδ1 expression, expressed an
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FIGURE 11 | Surface Vβ expression of αβT cells in comparison with peripheral Vδ1+ T cells in healthy and diseased individuals.
(Continued)
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FIGURE 11 | Continued
(A) Representative Vβ family staining pattern (exemplarily shown are nine
different Vβ families) on αβT cells and Vδ1+ T cells in peripheral blood MNCs
shown for one healthy individual and for one individual suffering from viral
infection. MNCs were stained with the TCR Vβ Repertoire Kit (Beckman
Coulter); three different Vβ family expressions are assessed in the same tube
by combining three monoclonal antibodies (mAb) with only two fluorophores
(see Materials and Methods for detailed information). (B) Percentage of Vβ+
expressing cells in the Vδ1 subset in healthy (n= 6) and diseased individuals
(n=5). (C) Percentage of Vδ1 cells with a Cδ+Cβ+ phenotype in healthy
(n=11) tissue differs significantly from that of body fluids of inflamed tissue
(n=14) (p=0.0343). (D) CD3+ cells that are Cγneg. and TCR-αβ
framework-epitopeneg. (DN for TCR) in healthy (n=11) and diseased individuals
(n=4). One representative blot is shown.
FIGURE 12 | Scheme for the transdifferentiation of Vδ1+ CD34dim
precursors into αβT cells inflammatory stimuli induce Vδ1+ CD34dim
precursors to move from the bone marrow into the periphery and
express CD4+. Chemokine receptors guide Vδ1+ CD4+ precursors to the
sites of inflammation where inflammation-associated stimuli induce their
development into αβT cells: Vδ1+ CD4+ cells sequentially rearrange,
transcribe and express Vβ chain intracellularly, while downmodulating
TCRγ and to a lesser extent Vδ1 expression. The Vβ chains then appear
on the surface of Cγlo/neg. cells and δ+β+ precursors transit into the
CD4+CD8+ DP stage where processive rearrangement in the α
locus – accompanied by the expression of RAG and TdT – deletes the
δ-chain, leading to the successive loss of Vδ1 on Vδ1dimVβ+ cells. Vβ+
chains preferentially pair with newly formed α chains in Vδ1dim/neg. Vβ+
cells that become weakly positive for TCR-αβ before they completely
lose Vδ1 expression, upregulate TCR-αβ and become mature and
functional SP CD4+ or CD8+ αβT cells.
αβTCR and developed into functional SP CD4+ or CD8+ αβT
cells.
In order to exclude these observations as artifacts of ex vivo
culture systems, we compared our findings with established liter-
ature data, and in order to identify its physiological relevance, we
aimed to show analogs of this new developmental pathway in vivo.
Several groups of researchers have shown that around 10–20%
of all peripheral γδ T cells transcribe and express in-frame TCR-
β rearrangements (63–65) that can guide αβT-cell development,
resulting in fully functional, mature T cells (66). Consistent with
these findings, CD4+ Vδ1+ clones transcribed in-frame TCR-β
chain rearrangements, showed cytoplasmic protein expression of
TCR-β chains, and expressed the TCR-β chain on their cell surface
as they bound BMA031. This is in accordance with the findings
of Miossec et al. (67) who showed that up to 45% of peripheral
Vδ1+ cells bind Cβ region-specific monoclonal antibodies (mAb)
BMA031. Using a set of mAbs that recognize the variable domain
of 24 different human Vβ chains, we refined our analysis in order
to demonstrate that peripheral Vδ1+ T cells of healthy individuals
expressed the full spectrum of Vβ chains. While Miossec and other
researchers showed that the Vδ1+ variable region can substitute Vα
in functional T-cell receptorα-chains and thus serve as an agent for
Vβ surface expression in the peripheral αβT cell subset (67–71), in
the current study we identified a subset in every CD4+ Vδ1+ clone
analyzed, which lacked surface Cα – because the clone culture did
not bind to T10B9.1A-31 that recognizes the TCR-αβ framework
epitope and did not transcribe a Vδ1Cα rearrangement. Neverthe-
less, the subset still showed surface Vβ expression while at the same
time being negative for TCR-γ. A T cell that lacks TCR-α, which is
the preferred binding partner of TCR-β, can express TCR-β on its
cell surface either in dimerized form with pre-Tα (72–74) or as a
homodimer, as had been suggested for thymic T-cell development
before pre-TCR was identified (75). Given that Vβ+-expressing
CD4+ Vδ1+ T cells are αβT-cell progenitors, they need to ensure a
controlled developmental transition beyond the DN3 stage to the
DP stage, which is limited to cells that have functionally rearranged
www.frontiersin.org December 2014 | Volume 5 | Article 645 | 15
Ziegler et al. Vδ1+T cells can develop into αβT cells
TCR-β chain genes that can pair with TCR-α. The complete lack
of pre-Tα mRNA in all clones and panVδ1+ cultures investigated,
along with the fact that TCR-δ has the same constant domain size
and the same spacing of the basic residues in the transmembrane
region as the TCRα chain (76), thus enabling TCR-δ to physically
pair with TCR-β (60) in the absence of TCR-γ (60), suggests an
intriguing scenario that does not involve a pre-TCR generation,
which requires pre-Tα, i.e., the pairing of TCR-β with TCR-δ for
Vδ1+Vβ+ surrogate pre-TCR.
The idea of Vδ1+Vβ+ pairing conforms with the findings of
Hochstenbach et al. who described Vδ1+Vβ+ heterodimers on
the CD4+ T-cell fraction derived from a human Vδ1+ Cγneg.
Burkitt lymphoma (DND-41), established from pleural effusion
(60). Thus, the formation of Vδ1+Vβ+ heterodimers on Vδ1dim
cells for surrogate pre-TCR seems completely feasible and would
also make sense in terms of the quantity of pre-TCR surface
expression, because the pre-TCR is expressed 50 to 100-fold
lower than the TCR-αβ on mature T cells, as is the pre-B cell
receptor (BCR) on the surface of pre-B cells (77). Consistently,
Vδ1dim cells show low Vδ1+ and Vβ+ expression. Accordingly,
the Vδ1+Vβ+ heterodimer for pre-TCR would add to the list of
other surrogate pre-TCRs that have been described to promote
progression of DN thymocytes to the DP stage in various model
systems, including γδ (78–83),αβ(84–87),αγ (88), and pTα/γ (89)
heterodimers.
As Vδ1+Vβ+ pairing only occurs in the absence of the γ-chain,
TCR change requires downregulation of γ-chain protein expres-
sion. Thymocytes progressively downregulate TCR-γ expression
from the DN3 to the DP stage to the relatively low level found in
mature peripheral αβ T cells (4). CD4+ Vδ1+ clones, correspon-
dently to the markers that they expressed – which are consistent
with DN3 thymocytes – showed a cell fraction that expressed Vδ1+
at low level, and were low/neg. for TCR-γ(Cγlo/neg.). The signifi-
cantly higher in vivo TCR-γ expression on Vδ1+ T cells compared
to Vδ2+ T cells in bone marrow and peripheral blood was unex-
pected (Figure 10C). This observation was put into perspective
during inflammation when TCR-γ expression was significantly
increased in the Vδ2+ compared to the Vδ1+ T-cell subset in the
peripheral blood of diseased individuals, while TCR-γ expression
remained unchanged in Vδ1+ cells (Figure 10C).
When CD4+Vδ1+ clone cultures were compared withγδ+ sub-
sets in vivo, the TCR-γ expression levels of the clones (chronically
exposed to inflammation) were identical to those observed in the
Vδ2+ but not to those observed in the Vδ1+ subset in the blood
of diseased individuals. In contrast, the CD4+ Vδ1+ clone frac-
tion that underwent TCR change was identical to the peripheral
Vδ1+ subset. This indicates that, in contrast to all other Vδ1+ cells,
CD4+Vδ1+ T cells have the capacity to modulate TCR expression,
possibly due to the disulfide bond that links the constant region of
Cδ to the Cγ1 segment of their TCR, a similarity they share with
the Vδ2 TCR. In addition, they can downregulate TCR-γ chain
expression during the process of transdifferentiation (Figure 6A).
Presuming that the Vδ1+Vβ+ heterodimer is a surrogate pre-
TCR in Vδ1loCγneg. T cells, signals that trigger Vβ chain selection
would require CXCR4 (90) and GATA-3 (91). Accordingly, CD4+
Vδ1+ γδ T-cell clones express high amounts of GATA-3, which
allows them to control the translation of TCR-β mRNA into
protein (92, 93), to increase in cell size, which is a feature that
accompanies pre-TCR expression in DN3 (92, 93), and to traverse
the conditional developmental arrest of the β-selection checkpoint
into DN4 stage (92, 93). Moreover, GATA-3 positively regulates
the transcription enhancer Eα, which is crucial for the initiation
of rearrangement and expression of TCR-α (94). In this context, it
was not surprising that the regulatory regions of both the TRAV-
26-2 segment and the TRBV30 segment share a GATA-3-binding
cis element (95). Additionally, CD4+ Vδ1+ T-cell clones simulta-
neously express the hallmark molecules RAG and TdT that guide
thymocytes from DN3 through to the DP stage.
These results substantiate the assumption that distinctive
Cβ-expressing CD4+ Vδ1lo/neg. Cγneg. T cells, CD4+CD8+ DP
Vδ1lo/neg. Cγneg. T cells and TCR-αβ+ SP CD4+ or SP CD8+
Vδ1lo/neg. Cγneg. T cells that are present in CD4+ Vδ1+ clone
cultures are cellular intermediates resulting from the successful
traversal of β-selection. Similar to the situation with immature
CD4+CD8+-expressing “thymocytes” that express the antigen
receptors and undergo positive and negative selection, which is
the core process of αβT-cell development.
Our finding that newly generated CD4+ Vδ1+ clone-derived
αβT cells underwent cell death when exposed to high-affinity
ligands such as antibodies that specifically targeted surface
Vβ chain, CD3 (soluble OKT-3), or CD3/CD28, supports
the assumption that selection accompanies transdifferentiation
(not shown).
Moreover – in analogy to the process of positive selection in the
thymus – RAG expression was repressed in panVδ1+ cell cultures
after the emergence of αβT cells (Figure 7C). We then verified our
findings with published molecular data. The finding that TRBV30
was expressed in clones and in panVδ1 cultures as initial TCR-β
chain, points to the outstanding role of TRBV30 segment regula-
tion and function (59). The TRBV30 segment is unique as it is the
only β segment located outside the main cluster, but downstream
of the J and C segments and forming the 3′ end of the locus. The
TRBV30 segment has the opposite transcriptional orientation to
the other segments, and must therefore be rearranged by inver-
sion of the Dβ, Jβ, and Cβ gene segments. This is in contrast to
the rearrangement of all other Vβ segments – and is not deletional
(59). Thus, rearrangements involving TRBV30 open up theβ locus,
and enable the subsequent rearrangement of other segments.
Moreover, TRBV30 segment chromatin access is biallelic (pre-
viously shown for mVβ14, the ortholog of TRBV30 in mice),
and recombinational accessibility is not downregulated by TCRβ
chains (96). TRBV30 transcripts were replaced by transcripts of
other β rearrangements in clones and panVδ1 cultures at later
time points, corresponding to the occurrence of β chains on
the cell surfaces in FACS analysis. This indicates subsequent sec-
ondary rearrangements that possibly involve mechanisms earlier
described for allelic inclusion and TCR revision in CD4 and CD8
αβT cells (97–100). The peculiarities in the regulation of the
TRBV30 segment – independence of the elements that control
access and rearrangement in the main cluster (59), an increased
accessibility in thymocytes that transit from DN to DP stage in
contrast to all other Vβ segments (101), and the lack of allelic
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exclusion and feedback inhibition (96) – has led to the assump-
tion that the TRBV30/mVβ14 segment (59) has an entirely distinct
function in vivo. Our data strongly support this argument.
Moreover, the de novo α rearrangement in Vδ1+ precursor cells
followed the exact hierarchical order of thymocytes that begin α-
locus recombination with the 3′ end Vα and 5′ end Jα segments,
from where the process proceeds to the distal ends of the locus (52).
PanVδ1+ cultures rearranged the TRAV segments TRAV-26-2, 26-
1, and -24, which corresponds exactly to encyclopedic knowledge
about the initiation of TCR-α locus rearrangement (52). Moreover,
as these segments are interspaced in the δ locus, and removed when
a functional TCR-δ1 chain is generated, de novo TCR-α rearrange-
ments must occur on the chromosome where the α locus is still
in germline configuration, rendering synchronous expression of
TCR-α and TCR-δ possible. This does not exclude the possibility
of TCR-δ genes replacing conventional TCR-α genes during the
rearrangement of theα-locus, and forming hybrid Vδ1JαCα chains
(67–71). VδJαCα hybrid chain transcripts were detected in few
panVδ1+ T-cell and some CD4+Vδ1+ clone cultures (not shown).
Moreover, our data are also consistent with the view that the TCR-α
locus underlies tight regulation and that the TCR repertoire is not
a vast and chaotic morass, but rather a patterned and perhaps even
predictable system (102). Coherently, we found the same α-chain
segments rearranged in response to identical epigenetic stimuli in
multiple donors, and overlapping sets of α-segments rearranged
in response to slightly modulated triggers.
CD4+ Vδ1+ T cells also reveal an analogy with thymic TCR-α
gene recombination, which lacks allelic exclusion but continues
until a functional α chain can form an MHC-restricted TCR with
the β chain (103) so that multiple V/J recombination events are
able to occur on the same allele (11, 104). Likewise, the proces-
sivity that correlates with the lifespan of the precursor cell (105)
was reproduced, CD4+ Vδ1+ T cells with superior viability (more
than 1 year in uninterrupted culture) exhausted the α-locus. The
clone-derived αβT-cell line K1.1 changed TCR months after the
establishment and showed rearranged TRAV-26, -25, -14 and -3,
αβ T-cell line P7 rearranged TRAV-26-2, -26-1, -24, -19, -14, -10,
and -2 segment.
CHARACTERIZATION OF THE αβT CELLS GENERATED
To test functionality, the CD4+ Vδ1+-clone-derived TCRαβ+
T-cell lines K1.1 and P7 that lacked CD28 were examined in
greater detail. These T-cell lines revealed an impaired prolifera-
tive response to mitogenic stimuli and carried public TCRs, as
reported previously for viral and autoimmune diseases (Table 1)
(53–59). This is consistent with the CD28− phenotypes’ high fre-
quencies of functional virus-specific memory CTL that mediate
TCR-mediated lysis (55). Constitutive IL-4 secretion and signif-
icant production of IFN-γ upon TCR stimulation showed that
K1.1αβ+ and P7αβ+ were functional (Figure 5D).
Other CD4+ Vδ1+-clone-derived αβT cells had an effector-
memory phenotype, some expressed CD28 while others did not,
and a broad Vβ and Vα repertoire (not shown). They had no
TRM phenotype, were negative for CD103 and were also CCR7lo
or negative and expressed varying amounts of CD62L and CD28
(not shown). Thus, Vδ1+-derived T cells had diverse but distinct
cell-surface phenotypes, a complex T-cell receptor repertoire, and
produced diverse cytokines. They could thus be classified as “func-
tional” Th type cells. The TCRs sequenced were identical to viral
antigen-specific TCRs (Table 1). The findings suggest that αβT
cells that arise extrathymically from Vδ1+CD34dimCD4+ prog-
enitors have a memory phenotype that enables them to respond
rapidly to environmental challenges.
PHYSIOLOGICAL RELEVANCE
To date the molecular determinants for thymic homing are miss-
ing, and it has been shown that neither the three-dimensional
thymic microenvironment nor thymic epithelial cells are essen-
tial for T-cell development (106). Answers to the questions as to
why the thymus provides a unique environment for T-cell dif-
ferentiation and whether the differentiation of the broad range
of TSP cells proceeds via a single canonical or via rather mul-
tiple pathways remain equally elusive (107, 108). Despite these
uncertainties, the CD4+ Vδ1+ T-cell precursors show high con-
sistency with the thymocytes’ phenotypic and functional behavior
and the transition through strictly defined stages on an invariable
differentiation route. The underlying genetic and physiological
processes are largely identical on the molecular level, and it is evi-
dent that transdifferentiation is an efficiently controlled and thus
a significant developmental pathway. Moreover, CD4+ Vδ1+ T-
cell precursors – which express markers of TSP, DN1-DN3, and
ISP progenitors – were as effective in generating mature αβT cells
as DP thymocytes are. DP cells, constituting more than 90% of
thymocytes, are selected for an MHC-restricted receptor, which
is thought to occur relatively infrequently (109, 110) and results
in the differentiation of only 1–2% DP precursors into mature
T cells. The number corresponds exactly with what we found,
namely, which 1 in 50 CD4+ Vδ1+ clones changed the TCR, and
panVδ1+ cultures reproducibly generated 1.82% SP CD4+ and/or
SP CD8+ αβT cells/panVδ1+ cell pool. Importantly, while homeo-
static expansion reduces the complexity of theαβTCR repertoire in
relation to the total number of αβT cells,CD4+Vδ1+ T-cell transd-
ifferentiation creates greater complexity of theαβTCR repertoire as
the progenitors de novo generate a broad spectrum of new αβTCRs
in the process of transdifferentiation. This may help assure that
even centenarians can acquire immunity to newly encountered
antigens.
Moreover, elevated precursor numbers and Vδ1+Cβ+ trans-
differentiation intermediates were found in the body fluids of
inflamed tissue (peripheral blood, pleura, inflamed joints, and
ascites), which is in line with the observation that the number of
Vδ1+ γδT lymphocytes is expanded in human diseases, including
infections (111–114), but also rheumatoid arthritis (115), multiple
sclerosis and HIV (116). This indicates that transdifferentiation is
a highly economical process that only takes place in inflamed tis-
sues that require T cells with diverse and adaptive TCRs. The high
consistency with thymocytes in terms of the developmental route
and productive efficacy thus suggests that the replenishment of the
peripheral αβT-cell pool through Vδ1+-descendants is one strong
principle in T-cell homeostasis.
In summary, this study describes the unique, previously
unknown role of peripheral CD4+ Vδ1+ γδT cells as αβT cell
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precursors that can respond to hematopoietic stressors such as
inflammation by differentiating into functionally, mature αβT
cells at the site required. We describe the expression of HSC and
progenitor markers as this subset’s peculiarity. We pinpoint the
transdifferentiation of CD4+ Vδ1+ γδT cells as a process of TCR
re-organization that is embedded in a developmental route simi-
lar to thymic αβ T-cell development but distinguishable from the
latter by Vδ1+Vβ+ CγnegCαneg intermediates, which suggests the
formation of Vδ1+Vβ+ heterodimers for surrogate pre-TCR. The
conclusions drawn from the in vitro data are strongly supported
by the results of ex vivo analyses of diverse body fluids, where the
progenitor’s Cβ-expressing Vδ1dimCγlo/neg transdifferentiation
intermediates were detected in inflamed tissue.
Most importantly, the study provides a conceptual framework
for a central goal of (developmental) immunology, namely, to
understand how T-cell development is ultimately conducted in
the absence of thymic function. The assignment of this funda-
mental role for γδT cells opens a new vista in immunology and
requires reevaluation of adaptive immune responses in infection,
autoimmunity and cancer.
MATERIALS AND METHODS
All procedures were carried out according to the Declaration
of Helsinki and were approved by the Clinical Ethics Com-
mittee at the University of Tübingen (projects 38/2009B02 and
470/2013B02).
SEVEN-COLOR FLOW CYTOMETRY
Cells were pretreated with FcR Blocking Reagent (Miltenyi
Biotec) according to the manufacturer’s instructions, resuspended
in flow cytometry buffer [PBS, 2% (vol/vol) FCS, 250 mM
EDTA] and incubated for 15 min (8°C, in the dark) with one
or more of the following monocolonal antibodies, all spe-
cific for human epitopes: FITC-anti-Vδ1, unconjugated anti-
Vδ1 (TS8.2, Fisher Scientific), APC-anti-TCRγδ (B1, BioLe-
gend), PE-anti-TCRγδ (recognizing Cγ; 11F2, BD Pharmin-
gen), PE-anti-TCRγδ (recognizing Cδ; SA6.E9, Life Technolo-
gies) PE-anti-TCRαβ (T10B9.1A-31, BD Pharmingen), FITC-anti-
TCRαβ (WT31, BD Pharmingen), murine anti-human TCR-αβ
mAb (BMA 031, Behringwerke Marburg). PE-anti-Vδ2 (B6, BD
Pharmingen), FITC/PE/PerCP-anti-CD4 (SK3, BD) or Vioblue-
anti-CD4 (VIT4, Miltenyi Biotec), FITC/PE/PerCP/APC-anti-
CD3 (SK7, BD) APC-anti-CD3 (MEM57, Exbio), APC-anti-
CD8β (2ST8.5H7, BD), and APC-H7-anti-CD8α (SK1, BD).
FITC/APC-anti-CD62L (LT-TD180, ImmunoTools), PE/APC-
anti-CD25 (2A3, BD Pharmingen), PE-anti-CD135 (4G8, BD
Pharmingen), PE-anti-CD127 (M21, BD Pharmingen), and APC-
anti-CD132 (4G3, BD Pharmingen). All IgG isotypes and sec-
ondary antibody rat anti-mouse IgG 1-PE (X56) were purchased
from BD Pharmingen. Cytokines were detected by intracellular
staining using standard procedures, and with APC-conjugated
anti-IL-2 (MQ-1-17H12), -IL-4 (MP4-25D2), -IL-5 (TRFK5), -IL-
10(10JES3-19F1), -IL-13(JES10-5A2), -TNF-α (MAb11), -IFN-α
(B27), all from BD Pharmingen, PE-anti-IL-17A from BioLe-
gend, and biotinylated-anti-TGF-β (MAB240) from R&D Systems.
Streptavidin conjugated with APC or PE (Invitrogen) was used
for the detection of biotinylated antibodies; the cells were trans-
ferred into new vials after each washing step in order to reduce
background and exclude false positive results.
In order to exclude dead cells from being analyzed, all cells
were subject to live/dead exclusion using the Alexa Fluor 350 NHS
Ester kit. In order to exclude the possibility of contaminants from
feeder cells, irradiated feeder cells were cultivated and analyzed as
clone cultures and used as controls in all experiments performed.
Cells were analyzed using LSR II or FACS Calibur systems, and the
FACS Diva©software and CellQuest software programs were used
for the acquisition and analysis of flow cytometric data.
TRBV repertoires were analyzed with the IOTest® Beta Mark
Kit (Beckman Coulter), a multi-parametric analysis tool designed
for the quantitative flow cytometric determination of the TCR
Vβ repertoire of human T lymphocytes. Taking advantage of the
fact that Vβ specificities may be grouped into mutually exclusive
combinations, three Vβ expressions can be detected in the same
tube using an innovative staining strategy that uses three mAb
stained with two fluorophores only. One mAb is conjugated to a
FITC molecule, the second to PE and the third one is a carefully
balanced mixture of a PE- and a FITC-conjugated form.
IMMUNOFLUORESCENCE
Vδ1+ CD4+ T-cell clones were harvested from culture dishes and
washed twice in sterile 1×PBS. For TCR-β chain expression analy-
sis, cells were applied to the slides by cytospin, fixed in −20°C
acetone/methanol (50/50; 2 min), and stained with mouse-anti-
human TCR Beta F1 (1:50) (8A3, Thermo Scientific). Cy™ 3-goat-
anti-mouse IgG (1:400) (Jackson ImmunoResearch) was used to
visualize TCR-β chain expression. Slides were analyzed with an




RNA was isolated using the RNeasy Plus Mini Kit (Qiagen). cDNA
was synthesized using the Superscript III First Strand Synthesis
Super Mix formulation (Invitrogen). All cDNAs were tested for
the expression of a 800 bp amplicon of β-actin.
Real-time PCR
cDNAs derived from CD4+ Vδ1+ clones and from panVδ1+
cultures were analyzed with ABI TaqMan primer/probe sets
for PTCRA (Hs00300125_m1), GAPDH (Hs02758991_g1), and
RORC (Hs01076122_m1), all purchased from Life Technologies.
All other primers are self-designed and are available upon request.
Invitrogen’s TaqMan assay reagent and BioRad’s IQ Master Mix
were used for qPCR. Gene expression was calculated using the
change-in-threshold method [∆C(T)] and GAPDH as reference.
TRAV chain analysis
Done in accordance with Han et al. (117).
TRBV spectratyping
Performed according to Gorski et al. (118) with minor modifica-
tions. 5′FAM-labeled BC primers were used, PCR amplicons were
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detected using an ABI 3130xl Genetic Analyzer, the GeneScan 600
LIZ dye size standard,and the GeneMapper software (both Applied
Biosystems).
γδ immunoscope
Performed with discriminating primers obtained from Annik Lim
and according to her protocol (personal communication).
Identification of TCR-CDR3 regions
The relevant PCR products required for spectratype analysis were
reamplified with unlabeled C primer. Sequencing was performed
with the 3130xl Genetic Analyzer (Applied Biosystems) using the
BigDye Terminator v3.1 Sequencing Kit according to the manufac-
turer’s protocol. Translation of the cDNA sequence into the protein
sequence was conducted with the EMBOSS Transeq software,
which is available free of charge (119, 120).
CELL CULTURE, SELECTION, AND CLONING EXPERIMENTS
Informed consent was obtained from all volunteers. Sterile
heparinized peripheral blood was collected from normal, healthy
donors (n= 12); healthy bone marrow were leftovers from HLA-
typing of potential stem-cell donors (n= 10), aliquots of LPH
were leftovers from quality control after graft generation (n= 12).
All samples were obtained and handled according to the Dec-
laration of Helsinki and the procedures were approved by the
Clinical Ethics Committee at the University of Tübingen. PBMCs
were isolated by density centrifugation (Ficoll-Hypaque). Up to
2× 107 PBMCs were pretreated using FcR Blocking Reagent (Mil-
tenyi Biotec) according to the manufacturer’s protocol, stained
with FITC-anti-Vδ1 (TS8.2, Fisher Scientific) using 10µl antibody
per 1× 107 PBMCs (15 min, +8°C, in the dark). Subsequently,
the Anti-FITC MultiSort Kit (Miltenyi Biotec) was used for the
isolation of “dim” cells. The cells were separated with columns
(Miltenyi Biotec). FACS analysis usally had a purity of>99% Vδ1+
T cells and less than 0.16% αβTCR+ cells. Alternatively, Vδ1+ γδT
cells were selected with the Anti-TCRγ/δMicroBead Kit (Miltenyi
Biotec).
For the establishment of Vδ1+CD4+ T-cell clones, Vδ1+ T
cells were enriched for CD4 using the Dynal® CD4 Positive Iso-
lation Kit (Invitrogen). All procedures were carried out accord-
ing to the manufacturer’s instructions. Vδ1+ CD4enriched T
cells were cloned using the limiting dilution procedure (0.1
cells/well) in round bottom 96-well plates in the presence
of 200 IU/mL IL-2 (ImmunoTools), 1.0 ng/mL IL-7 (Immuno-
Tools), 0.25µg/mL phytohemagglutinin (Oxoid), and 1× 105
allogeneic, 80 Gy-irradiated feeder cells. After 21 days, Vδ1+
CD4+ T-cell clones were identified by FACS analysis and
kept under standard culture conditions – which represents
mild inflammation – until further manipulation and analysis.
Cloning strategy routinely yielded 5–10% of initially seeded
Vδ1+CD4+ T cells (0.1 cells/well). For panVδ1 culture assays,
1,000 Vδ1+ cells were seeded per well in round bottom 96-
well plates and cultured in RPMI 1640 supplemented with
10% heat-inactivated FCS, L-glutamine (4 mM), and peni-
cillin (50 U/mL)/streptomycin (50µg/mL), all purchased from
Biochrom GmbH.
Overt inflammation was mimicked in panVδ1 cultures by
adding the following cytokines to the standard culture medium in
week 3: IL-1β (10 ng/mL; ImmunoTools), IL-18 (10 ng/mL; R&D
Systems), IL-6 (50 ng/mL; ImmunoTools), sIL-6R (100 ng/mL;
ImmunoTools), and IL-12 (10 ng/mL; ImmunoTools). Monocytes
that had been preactivated for 3 days in the presence of these
inflammatory cytokines were also added to the culture. Mono-
cytes were generated from PBMNCs by plastic adherence in cell-
culture flasks for 2 h (PBMNC density 1.5× 106/mL in RPMI 1640
standard medium; 5% CO2, water-saturated atmosphere, 37°C).
Non-adherent cells were subsequently removed along with the
supernatant; adherent cells were washed twice with warm PBS,
and new culture medium containing inflammatory cytokines was
added. After 3 days, the monocytes were removed from the bottom
of the culture flask with a cell scraper, counted, centrifuged, resus-
pended in conditioned medium, irradiated (80 Gy), and 1× 105
monocytes/well added to panVδ1+ cell cultures.
FUNCTIONAL ANALYSIS
αβT cells derived from transdifferentiated Vδ1+ CD4+ γδ T-cell
clones were stimulated for 5 h with PMA (50 ng/mL) and iono-
mycin (750 ng/mL, Sigma). Brefeldin A (10µg/mL) was added for
the last 60 min of incubation. Cytokine production was measured
by intracellular staining and FACS analysis as described above.
STATISTICAL ANALYSES
Statistical analyses were performed with the GraphPad Prism
software V5.0 (GraphPad Software). Statistical differences were
analyzed using the parametric student t -test, error bars in the
graphs depict the SEM. A p< 0.05 was considered as statistically
significant.
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